LPTX News and Press, Leap Therapeutics Inc. From 09/24/20

Sunworks (SUNW) +355%.Polar Power (POLA) +88%.The E.W. Scripps Company (SSP) +68% on ION Media acquisition.SPI Energy (SPI) +51%.LogicBio Therapeutics (LOGC) +45%.Owens & Minor (OMI) +28% after raising full-year guidance.Electrameccanica Vehicles (SOLO) +16% ...

USFDA granted Leap Therapeutics (LPTX) +8.8% fast track designation to DKN-01 for the treatment of patients with gastric and gastroesophageal junction (G/GEJ) adenocarcinoma whose tumors express high Dickkopf-1 protein (DKK1), following disease progression on or after prior fluoropy...

Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer PR Newswire CAMBRIDGE, Mass., Sept. 24, 2020 CAMBRIDGE, Mass. , Sept. 24, 2020 /PRNewswire/ -- Leap Therapeutics...

Leap Therapeutics (LPTX) up 7.2% in premarket, and BeiGene, (BGNE) have announced that first patient has been dosed in the DisTinGuish Phase 2a trial, evaluating Leap's DKN-01, in combination with latter's tislelizumab, with or without chemotherapy in patients with gastric...

Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer PR Newswire CAMBRIDGE, Mass. and BEIJING, Sept. 21, 2020 CAMBRIDGE, Mass. an...

Leap Therapeutics (NASDAQ: LPTX ) has filed a preliminary prospectus for a $150 mixed shelf offering. More news on: Leap Therapeutics, Inc., Healthcare stocks news, , Read more ...

CAMBRIDGE, Mass. , Sept. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi , President and Chief Executive Officer, will present a corporate ove...

A Penny Stocks List For September Should your list of penny stocks include hundreds of names? Honestly, when you’re putting together a watch list, you should keep a few things in mind. First, buying shares of every stock on that list isn’t efficient. You want to stay focused. F...

CAMBRIDGE, Mass. , Aug. 24, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the expansion of its leadership team with the appointment of Jason S. Baum , Ph.D., as Vice Pr...

Leap Therapeutics (NASDAQ: LPTX ) : Q2 GAAP EPS of -$0.12 beats by $0.06 . More news on: Leap Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...